Anti-Cancer Potential of Phytochemicals: The Regulation of the Epithelial-Mesenchymal Transition.
Shuangyu LiuLingyu LiDong-Mei RenPublished in: Molecules (Basel, Switzerland) (2023)
A biological process called epithelial-mesenchymal transition (EMT) allows epithelial cells to change into mesenchymal cells and acquire some cancer stem cell properties. EMT contributes significantly to the metastasis, invasion, and development of treatment resistance in cancer cells. Current research has demonstrated that phytochemicals are emerging as a potential source of safe and efficient anti-cancer medications. Phytochemicals could disrupt signaling pathways related to malignant cell metastasis and drug resistance by suppressing or reversing the EMT process. In this review, we briefly describe the pathophysiological properties and the molecular mechanisms of EMT in the progression of cancers, then summarize phytochemicals with diverse structures that could block the EMT process in different types of cancer. Hopefully, these will provide some guidance for future research on phytochemicals targeting EMT.
Keyphrases
- epithelial mesenchymal transition
- signaling pathway
- transforming growth factor
- induced apoptosis
- stem cells
- cancer stem cells
- bone marrow
- pi k akt
- papillary thyroid
- high resolution
- risk assessment
- cell cycle arrest
- mesenchymal stem cells
- climate change
- lymph node metastasis
- endoplasmic reticulum stress
- replacement therapy